serious mental illness and related medical disorders (for example, hypothyroidisminduced depression, side effects of drugs, and adverse drug interactions), consistent with psychology's theoretical approach to mental illness (3) . Psychiatrist board members consistently note that the pharmacologic training of their student psychologists surpasses training provided within traditional medical schools, and legislation has been passed to allow duly qualified psychologists to prescribe medicine in US federal hospitals, in the US territory of Guam, and most recently, in New Mexico. In the case of New Mexico, after all the evidence both for and against was reviewed, legislation that consigned autonomous prescribing authority to duly qualified psychologists passed with a vast majority of favourable votes and with the support of both the New Mexico Medical Association and a psychiatrist who provided expert medical testimony. In Canada, the province of Alberta has reportedly modified its health care legislation to allow duly qualified health care professionals to request prescribing authority.
In sum, clinical psychopharmacology is a well-established clinical psychological subspecialty (and hence, well past the "debating" stage of development) with a wealth of data from both psychiatrists and psychologists documenting the qualifications of practitioners within this specialty to prescribe medicine competently and safely. Psychiatrists should question why 2 psychologists, neither of whom is board certified to practice this specialty, are attempting to "stimulate the interest" of psychiatrists and to "educate" them so that they may become involved in this discussion-a discussion about whether duly qualified specialists within another discipline should be allowed to provide health care services within their scope of practice.
Reply: Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists
Dear Editor:
Further to Dr Litman's letter, in no way did we intend to convey the message that the psychological subspecialty of psychopharmacology is currently "undeveloped." We did state that the act of prescribing psychoactive medication deviates, not from psychology's theoretical approach to mental illness but, rather, from its traditional foundations as an academic discipline. We do not argue that psychopharmacology is inconsistent with psychological principles but that the feasibility and safety of actual prescribing has not been adequately evaluated. Clearly, the academic discipline of psychopharmacology is a wellestablished and evolving psychological specialty. Even as an academic discipline, however, it is relatively young, compared with the psychological specialties of cognitive science, abnormal psychology, or behaviourism.
We agree that standards for psychopharmacological training for psychologists have been established and pilot projects are underway. Nevertheless, there is a difference between medical evaluation and management of mental illness and actual prescribing. Psychologists have been competently diagnosing mental illness and monitoring medication side effects for years. The observation that some student psychologists received pharmacologic training surpassing that provided within traditional medical schools seems to underscore a problem within medical training; it is not necessarily sufficient to qualify psychologists to prescribe.
We agree that psychopharmacology is a well-established psychological specialty. Our article aimed to inform Canadian psychiatrists of the major issues and controversies of this debate. As for whether prescription privileges are within psychologists' scope of practice, we believe this question, at least for the time being, remains debatable.
Re: Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists
The review paper on the subject of whether psychologists should be granted prescription privileges (1) should be ensconced in the annals of psychiatric literature as characterized by obfuscation rather than enlightenment, notwithstanding the statement at the very end of the article that "psychologists need not go beyond the boundaries of psychological practice to expand into new treatment areas"-a mere sop in an article meant to condition and somehow advance the untenable practice of prescribing privileges to psychologists.
It is certainly a truism that allowing psychologists to prescribe would widen the scope of their practice and that this profession's accessibility to psychoactive medication would result in more people being "treated."
This tautological argument flies in the face of common sense. Perhaps bartenders, barbers, and hairdressers should also be given limited prescription privileges and, in the case of barbers, the right to do trephining as well! According to the spurious argument that length of education is a rationale for allowing psychologists to prescribe, nuclear physicists should be given unlimited prescription privileges in all areas of medicine and to all and sundry.
When psychologists become physicians and psychiatrists and, as a result, are subject to the same rigorous discipline and curriculum of etiology and the assessment and treatment of diseases, then no reasonable body or person can deny them prescribing authority.
It appears somewhat ludicrous that an article of this nature would grace the pages of the Canadian Psychiatric Association's journal when we are witnessing an evolution and revolution in psychiatry. Psychiatry is evolving into a truly scientific, neurobiological discipline that is deeply rooted in technological medicine and in rigorous medical scientific method.
Please leave philosophy to the philosophers, psychology to the psychologists, and yes, cheese to the cheese makers. 
Sam Sussman, PhD London, Ontario

Reply: Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists
Although we argued that pursuing prescription privileges at this time may be premature (owing to a relative lack of empirical support for the feasibility and safety of such a course and a lack of consensus among psychologists regarding its desirability), I would hardly call the idea "untenable"-particularly since it is already happening in various North American sites (for example, in US federal hospitals). We agree that length of education is not a strong argument to present in favour of awarding prescription privileges to psychologists; that is precisely why we listed it as one of the weaker arguments typically offered by proponents of prescription privileges. Listing such arguments was meant to stimulate discussion and rebuttal, and we are pleased that it did just that!
The discipline of psychology is also witnessing a revolution and evolution, a phenonomenon that is driving this debate. To suggest that psychology is not also concerned with neurobiology or the scientific method is inaccurate: the psychological disciplines of neuropsychology, psychobiology, and psychoneuroimmunology are all well developed and respected domains of science.
I would also like to point out that for years psychological research has focused on behavioural medicine and that more and more psychologists are finding clinical and research positions within medical faculties-highlighting the pertinence and relevance of psychology in medicine.
Kim Lavoie, PhD
Montreal, Quebec
Breath-Holding in Anxiety Disorders
The breath-hold test may be a simple and natural method of inducing endogenous CO 2 increase. We aimed to observe whether anxiety disorder patients (diagnosed according to DSM-IV criteria) respond in a similar way to the induction of panic attacks by a breath-holding test.
We randomly selected 29 panic disorder (PD) patients (18 women and 11 men; mean age 36.8 years, SD 9.6), 27 social anxiety disorder (SAD) patients (15 women and 12 men; mean age 42.8 years, SD 11.3), 21 generalized anxiety disorder (GAD) patients (14 women and 7 men; mean age 35.3 years, SD 15.0), and 23 comorbid anxiety disorder (CAD) patients (14 women and 9 men; mean age 37.5 years, SD 8.9) in the Laboratory of Panic and Respiration, Rio de Janeiro, Brazil. Our comparison group comprised 30 subjects with no family history of anxiety or mood disorder (18 women and 12 men; mean age 33.7 years, SD 13.8 years). We obtained written informed consent, and our local ethics committee approved the protocol. The inclusion criteria were as follows: age 18 to 55 years, occurrence of at least 3 panic attacks in the previous 2 weeks for PD patients, and a negative urine test for medications. Exclusion criteria were unstable medical condition, cognitivebehavioural psychotherapy during the study, and use of any psychotropic medication for 5 weeks.
To measure the baseline anxiety level, we asked subjects to complete (before and after the test) the Subjective Units of Disturbance Scale (SUDS) (1) and the Diagnostic Symptom Questionnaire (DSQ) (1) adapted for DSM-IV. Based on the DSQ, we defined a panic attack as 1) 4 or more symptoms of a panic attack according to DSM-IV criteria; 2) at least one of the cognitive symptoms; 3) feelings of panic or fear, similar to spontaneous panic attacks; and 4) the agreement of 2 diagnosis-blinded raters at clinical diagnosis evaluation.
The breath-holding test comprised 4 trials as used by Van der Does (2). The panic rates assigned showed that significantly more PD patients had a panic attack in response to breath-holding: 44.8% (n = 13) of PD patients, 14.8% (n = 4) of SAD patients, 9.5% (n = 2) of GAD patients, 13.0% (n = 3) of CAD patients, and 4.0% (n = 1) of control subjects had a panic attack after the test (P² = 23.67, df 4, P = 0.001). There was no significant sex difference in any group (P² = 0.64, df 4, P = 0.958).
Although the SUDS results showed that PD patients tended to be more sensitive than other groups, all groups showed increased anxiety levels after the test. There were no statistical difference among the groups (2-way analysis of variance [ANOVA], group-by-time interaction: F 4,125 = 1.283, P = 0.238).
Our main finding is the clear differentiation of PD patients from other anxiety disorder patients by a simple respiratory test. The precise criteria for induced panic attack may be the crucial point for our results. The data support Klein's
